GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, MMP12, MMP9, SMAD3, SRC, TEK |
7.6258 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, MMP12, MMP9, SMAD3, SRC, TEK |
7.6258 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.57369 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CSNK2A1, CYP1B1, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK |
7.17769 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.75133 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MCL1, MMP2, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.67172 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.64531 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.33738 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.31086 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.25846 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
6.13414 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, MMP12, MMP9, SMAD3, SRC, TEK |
6.13406 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK, TRPV1 |
6.09603 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.09603 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1B1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MCL1, MMP2, MMP9, PPARA, SMAD3, SRC, TEK, TRPV1 |
6.07314 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.02325 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK |
5.95319 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP9, NUAK1, SRC, TEK |
5.87335 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK |
5.87335 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SMAD3, SRC, TEK |
5.78579 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
5.74237 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
5.69481 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.69063 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.68571 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, MMP12, MMP2, MMP9, SMAD3, SRC, TEK |
5.5329 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.46461 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
5.43954 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.43349 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, CA12, CA2, CA7, CYP19A1, CYP1B1, EGFR, F10, FABP3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, PPARA, SMAD3, SRC, TEK, TRPV1 |
5.40026 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MCL1, MET, SRC, TEK |
5.29099 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, CA12, CA2, CA7, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MCL1, MET, SMAD3, SRC, TRPV1 |
5.27239 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
5.09298 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, MET, PPARA, TRPV1 |
5.09298 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MCL1, MMP9, PIM1, SMAD3, SRC, TEK |
5.05521 |
[BP] GO:0030335 |
positive regulation of cell migration
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.89056 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK |
4.88778 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, CA9, CSNK2A1, CYP1B1, EGFR, FABP3, IGF1R, INSR, MMP2, MMP9, PPARA, SRC, TEK, TRPV1 |
4.78641 |
[BP] GO:2000147 |
positive regulation of cell motility
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.77264 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, KDR, MCL1, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
4.73807 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.67591 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.6418 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALPL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
4.60745 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK |
4.58114 |
[BP] GO:0040017 |
positive regulation of locomotion
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.56456 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALPL, CYP19A1, CYP1B1, DUSP3, EGFR, F10, FABP4, IGF1R, INSR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
4.50839 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
4.49725 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
4.31008 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1B1, EGFR, F10, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MCL1, MMP12, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TRPV1 |
4.25353 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, CA1, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MCL1, MET, MMP2, MMP9, SMAD3, SRC, TEK, TRPV1 |
4.20871 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
4.19109 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK |
4.08636 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC, TRPV1 |
4.08636 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HSPA1A, PIM1, PPARA |
4.08636 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK |
4.01212 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1 |
3.84283 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3, TRPV1 |
3.81316 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, CA2, CA9, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MCL1, MMP2, MMP9, NUAK1, SMAD3, SRC, TRPV1 |
3.71697 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
3.71697 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
3.68877 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1 |
3.68877 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, INSR, MET, SRC, TEK |
3.60883 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1 |
3.56459 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, CYP1B1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC, TRPV1 |
3.53423 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.52665 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
3.45864 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DUSP3, EGFR, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK |
3.37255 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
3.35216 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP4, FLT3, FUT7, INSR, KDR, MCL1, MET, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
3.35048 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.35048 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.35048 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK |
3.34953 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, SMAD3, SRC |
3.32897 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, SMAD3, SRC |
3.31984 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK |
3.31984 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.28946 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CSNK2A1, CYP1B1, EGFR, FLT3, SRC, TEK, TRPV1 |
3.22175 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, CA2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FLT3, INSR, KDR, MCL1, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
3.15955 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
3.14676 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
3.11741 |
[BP] GO:0006468 |
protein phosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.11741 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC |
3.11639 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.11639 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, CA2, CA7, CYP19A1, EGFR, GPR35, HSPA1A, INSR, MMP12, MMP9, PPARA, SMAD3, SRC, TRPV1 |
3.05387 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1B1, CYP2A13, CYP2A6 |
3.04017 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
3.03275 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
3.03275 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, CSNK2A1, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
3.02732 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.02593 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
3.02583 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, FABP4, KDR, MET, MMP12, PPARA, SMAD3, TEK |
2.99998 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, KDR, SRC, TRPV1 |
2.98246 |
[BP] GO:0048513 |
animal organ development
|
ACHE, CA2, CSNK2A1, CYP19A1, EGFR, FLT3, INSR, KDR, PPARA, SMAD3, SRC, TEK |
2.98246 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.98246 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.98246 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, CA2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
2.97233 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, INSR, MET, SRC, TEK |
2.96457 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALPL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
2.95517 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.9161 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, CA2, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.91296 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.91296 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.91296 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.8959 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, SRC |
2.87614 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.87156 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.85744 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.72623 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1B1, CYP2A13, CYP2A6 |
2.71264 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, EGFR, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC, TRPV1 |
2.6979 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, CSNK2A1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
2.69542 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.67677 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
CA2, CYP1B1, EGFR, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
2.67677 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
EGFR, INSR, KDR, SMAD3, SRC, TRPV1 |
2.67677 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.67255 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.66701 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, CA1, CA2, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MCL1, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.66701 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, MMP12, SRC, TRPV1 |
2.61709 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, INSR, SMAD3, TRPV1 |
2.59604 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.59245 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, CA2, CA9, CYP1B1, EGFR, HSPA1A, MCL1, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.59245 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, FABP4, PPARA, SMAD3, TEK |
2.58494 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.57991 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.57991 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, MMP2, PPARA, SMAD3, SRC, TEK |
2.57779 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK |
2.57779 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, HSPA1A, INSR, KDR, MCL1, MET, PPARA, SMAD3 |
2.55751 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
2.55432 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, MCL1, MET, PPARA, SMAD3 |
2.55087 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.52961 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, MMP2, PPARA, SMAD3, SRC, TEK |
2.51927 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.49927 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.4786 |
[BP] GO:0016310 |
phosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.4786 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.45132 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, CYP1B1, EGFR, IGF1R, INSR, MMP2, MMP9, SRC, TRPV1 |
2.44396 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.44396 |
[BP] GO:0043434 |
None
|
FABP3, INSR, PPARA, SRC, TEK, TRPV1 |
2.44396 |
[BP] GO:0070848 |
response to growth factor
|
EGFR, INSR, KDR, SMAD3, SRC, TRPV1 |
2.43771 |
[BP] GO:1903426 |
None
|
EGFR, INSR, SMAD3, TRPV1 |
2.43244 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.43244 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, MET, SMAD3, SRC |
2.42155 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CYP1B1, EGFR, KDR, SRC, TRPV1 |
2.42155 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, TRPV1 |
2.4172 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, CA2, CYP19A1, EGFR, INSR, MMP12, SMAD3, SRC, TRPV1 |
2.417 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
2.38715 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.37084 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.37084 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, MMP2, PPARA, SMAD3, SRC, TEK |
2.36666 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.36502 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, SRC |
2.33064 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.32607 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, EGFR, PPARA, SMAD3 |
2.3236 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.31108 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.29303 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.28906 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, CA2, CYP1B1, EGFR, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
2.27653 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.26552 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.26552 |
[BP] GO:0030198 |
extracellular matrix organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.26065 |
[BP] GO:0043062 |
extracellular structure organization
|
CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.25499 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MCL1, MMP9, SRC |
2.24746 |
[BP] GO:0040011 |
locomotion
|
CYP1B1, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.24733 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, CSNK2A1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK |
2.23597 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, TEK |
2.22663 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK |
2.21492 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK |
2.19248 |
[BP] GO:0016477 |
cell migration
|
CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.19248 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, KDR, MMP2, SRC |
2.1861 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.1861 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, CA2, CA7, EGFR, KDR, SRC, TRPV1 |
2.17809 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
EGFR, HSPA1A, MET, SRC |
2.17809 |
[BP] GO:0030260 |
entry into host cell
|
EGFR, HSPA1A, MET, SRC |
2.17809 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
EGFR, HSPA1A, MET, SRC |
2.17809 |
[BP] GO:0044409 |
entry into host
|
EGFR, HSPA1A, MET, SRC |
2.17809 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, CSNK2A1, DUSP3, EGFR, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK |
2.17606 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, SRC, TEK |
2.15667 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
KDR, SMAD3, SRC, TEK |
2.15263 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALPL, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.13403 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.13403 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, EGFR, FABP3, GPR35, SMAD3, TRPV1 |
2.10792 |
[BP] GO:0030155 |
regulation of cell adhesion
|
CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.10792 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.06841 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, SRC |
2.06062 |
[BP] GO:0009268 |
None
|
CA2, SRC, TRPV1 |
2.06062 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP2A13, CYP2A6 |
2.06062 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP2A13, CYP2A6 |
2.06062 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, EGFR, FABP3, FLT3, INSR, KDR, MMP9, SMAD3, SRC, TEK |
2.05288 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, EGFR, FABP3, FLT3, INSR, KDR, MMP9, SMAD3, SRC, TEK |
2.05288 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.05288 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, CA9, CSNK2A1, CYP1B1, DUSP3, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
2.04446 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1B1, EGFR, FLT3, SRC, TRPV1 |
2.03871 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, FLT3, INSR, KDR, SRC, TEK |
2.03627 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, SRC |
2.02753 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, MET, SMAD3, SRC |
2.02312 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.02312 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, HSPA1A, IGF1R, MCL1, MET, MMP9, SRC |
2.01848 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, PIM1, SMAD3, SRC, TEK, TRPV1 |
3.39084 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
3.18761 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, CA2, CA4, CA9, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, SRC, TEK, TRPV1 |
2.57779 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, EGFR, INSR, MET, SRC, TEK, TRPV1 |
2.37084 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, CA4, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.28653 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALPL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, EGFR, F10, FLT3, FUT7, GPR35, IGF1R, INSR, KDR, MCL1, MET, MMP2, PIM1, SMAD3, SRC, TEK, TRPV1 |
2.24875 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, INSR, SRC, TRPV1 |
2.22758 |
[CC] GO:0032589 |
None
|
ADORA1, INSR, TRPV1 |
2.06062 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FLT3, FUT7, GPR35, IGF1R, INSR, KDR, MCL1, MET, SRC, TEK, TRPV1 |
2.01381 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.7265 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, EGFR, F10, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TRPV1 |
7.49728 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK |
7.17769 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.17769 |
[MF] GO:0046914 |
transition metal ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3 |
7.17769 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.8757 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.42486 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.32112 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.5329 |
[MF] GO:0008144 |
drug binding
|
ACHE, CSNK2A1, CYP19A1, CYP1B1, CYP2A13, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TRPV1 |
5.47081 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC |
5.25054 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
4.52365 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
4.4404 |
[MF] GO:0004672 |
protein kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.43421 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
4.33597 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6 |
4.05567 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.72158 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.6534 |
[MF] GO:0016301 |
kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.40376 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, F10, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, TRPV1 |
3.15316 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
CSNK2A1, DUSP3, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK |
3.11741 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.03275 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.88909 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, SRC |
2.85922 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.83304 |
[MF] GO:0005524 |
ATP binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.83002 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1B1, CYP2A13, CYP2A6, F10, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, TRPV1 |
2.82036 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.77209 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.72949 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6, SRC |
2.72623 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.71116 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1B1, CYP2A13 |
2.61976 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK, TRPV1 |
2.49576 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.47899 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, MMP1, MMP12, MMP2, MMP9 |
2.4172 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR |
2.38715 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK, TRPV1 |
2.29895 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.28966 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1B1, CYP2A13, CYP2A6 |
2.24746 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP2A13, CYP2A6 |
2.24281 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.24281 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.24281 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.17438 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR |
2.12583 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.1241 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK, TRPV1 |
2.12069 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.06062 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.06062 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.04684 |
[MF] GO:0043168 |
anion binding
|
CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.04272 |
[MF] GO:0017076 |
purine nucleotide binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.02753 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK, TRPV1 |
2.02608 |
[MF] GO:0032553 |
ribonucleotide binding
|
CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.025 |
[MF] GO:0004222 |
metalloendopeptidase activity
|
MMP1, MMP12, MMP2, MMP9 |
2.02082 |